Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (297)
ARTG (242)
Prescription medicine registration (23)

Date

2025 (18)
2024 (49)
2023 (48)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (14)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Search

Sponsor content

562 result(s) found, displaying 441 to 450

PERINDOPRIL-GA perindopril erbumine 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL-GA perindopril erbumine 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL-GA perindopril erbumine 8mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Levonorgestrel and ethinylestradiol LAPL 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Levonorgestrel and ethinylestradiol Lupin 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL/ INDAPAMIDE-GA 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MOXONIDINE LAPL, MOXONIDINE GENERICHEALTH, MOXONIDINE GH (Lupin Australia Pty Limited)

29 June 2018

Prescription medicine registration

Active ingredients: Moxonidine.
TADALAFIL GENERICHEALTH, TADALAFIL LAPL, TADALAFIL GH (Lupin Australia Pty Limited)

25 May 2018

Prescription medicine registration

Active ingredients: Tadalafil.
PREGABALIN LAPL pregabalin 200 mg capsule blister pack (215701)

5 December 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LAPL pregabalin 200 mg capsule blister pack.
PREGABALIN LAPL pregabalin 25 mg capsule blister pack (215702)

5 December 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LAPL pregabalin 25 mg capsule blister pack.

Pages

First page
Previous page
…
Page 41
Page 42
Page 43
Page 44
Current page 45
Page 46
Page 47
Page 48
Page 49
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.